arrow
D

Dan T. Vogl

University of Pennsylvania
H指数:50
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy

CD4 T细胞介导BCMA car-t细胞治疗后car-t细胞相关的免疫相关不良事件

2026-01-150
PRE
Outcomes of relapse after teclistamab therapy in multiple myeloma

接受特昔利珠单抗治疗后多发性骨髓瘤复发的结局

2025-11-050
OAAI
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025

NCCN Guidelines® Insights: 多发性骨髓瘤,版本 1.2025

2025-05-010
PRE
A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma

一项关于modakafusp alfa作为单药治疗复发/难治性多发性骨髓瘤患者的2期随机研究

Blood
IF23.1
2025-04-290
OAAI
Efficacy and Safety of Anti-CDI9 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma

抗CDI9和抗BCMA嵌合抗原受体(CAR)T细胞疗法在自身免疫性疾病、淋巴瘤或骨髓瘤患者中的疗效与安全性

BLOOD
IF23.1
2024-11-050
PRE
Tasquinimod, an S100A9 Inhibitor, in Combination with Ixazomib, Lenalidomide, and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Tasquinimod,一种S100A9抑制剂,与伊沙佐米、来那度胺和地塞米松联合用于复发性和难治性多发性骨髓瘤。

BLOOD
IF23.1
2024-11-050
PRE
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

商业CAR T细胞治疗后T细胞淋巴瘤和继发性原发性恶性肿瘤风险

2024-01-2481
PRE
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy

抗BCMA/CD19 CAR T细胞与多发性骨髓瘤的早期免疫调节维持对初始或后续治疗有反应

2022-11-2144
OAAI
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
2022-11-0910
OAAI
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
2022-02-1025
OAAI
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma
2021-11-3012
OA
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
2021-09-0610
OAAI
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking
2021-08-128
OA